Get started

PHARMA

Gennex Labs - Penny Stock - Buying OpportunityBeen tracking this pharma company since 2014 when it was trading at levels around Re.1 Since it being a penny stock it is difficult to apply technical analysis due to variety of reasons. However, the yearly support trendline is now making sense and provides an opportunity to buy it at current levels. Does it have a potential to be a multibagger - Who knows ? But currently there is a trading opportunity that i believe is worth the risk. Trade Strategy : Buy : 6.35 Target : 11.35 Stop Loss : 3.90 Risk to Reward - 2:1 Trade Safe !!!
BSE:GENNEXLong
by wildwildmoney
Aurobindo Pharma: No one can time the market........but when time comes, you will certainly make the most of it...:-) That's the advantage of interacting with charts directly... Identify levels...when they come be in a clear decision making mind frame to act...reap the benefits of listening to charts directly The stock has crossed our 1st target of 625 & in the process has also taken out 50 day EMA in style with good volumes. What next...??? The stock is currently on the brink of long term trend line break out and 674 zone where it will test 200 day EMA is the final litmus test for the stock. Watch out cause Auro is getting well soon...!!! On the lower side 50 day EMA should provide good support (buying opportunity) going forward... Take care & happy trading....
NSE:AUROPHARMALong
by indiamarketoutlook
Aurobindo: Will This Pill End The Pain ?! contd..This is the continuation of my previous long term analysis on Aurobindo As expected Aurobindo took nice support at 580 and rebound sharply upto the falling trendline of the downward sloping channel. Volume-Spread: As expected stock seems facing resistance near 620-630 levels. The volume however is declining. Stock had a huge volume at 'a' but long wick at the top says supply is there at 607. As this resistance level is crossed at 'b' we dun see a spike in volume, suggesting declining demand. A new high at 'c' but further declining volume, even less demand. New high at 'd', price juuuust crossed falling trendline with rise in volume but doji bar says indecision. So may be some profit booking started. Notice that the price declined thereafter that but volume is not picking up, it suggests that bulls are still holding and bears are not still active. Currently it is trying to build a support near 598 level. Although these are signs of consolidate near resistance yet I would say that, as mentioned in my earlier post, 580 is a key level to watch out for. Holding or breaking this support may decide the near term future of this stock. This is just an analysis and not an investment advice. I always respect if you have your own different opinion on the stock. Thanks Like, comment, share and follow.
NSE:AUROPHARMA
by Bravetotrade
4
LUPIN BUY (LONG)Lupin is a BUY at CMP@1470 with SL@1420 for a target of TP@1600 Lupin gets USFDA nod to market pain relief, colonoscopy drugs and also gets FDA approval for generic Percocet tablets . Lupin recently received FDA approval for generic Suprep Bowel Prep Kit and Suprep kit approval It may add 5% to Lupin’s EPS for FY18 earnings. In addition the pharma major’s Goa facility has been cleared by the US FDA. Lupin Result: Revenue grew 26% YoY to INR 44.8b Gross margin was stable QoQ at 71.0%. EBITDA rose 27% YoY to INR 12.2b with margin of 27% . EBITDA margin improvement was primarily driven by strong growth in US sales (+53% YoY, +8% QoQ; despite R&D as % of sales at 12.9%) and forex gain of INR 270m. PAT of INR 6.3b was impacted by 1% due to a high tax rate of 39%. Lupin is a BUY at CMP@1470 with SL@1420 for a target of TP@1600
NSE:LUPINLong
by VIRUSSOUL
Descending triangle - SanofiThe stock is showing strong support at the 4080 levels. The current pattern shows a descending triangle, constantly testing this support level for the past 3 months. The descending triangle is showing exhaustion as indicated by the Accum/Distribution trend. The A/D is a leading indicator that takes into account volume aspect of the trade as well. One should expect a downward movement to the 3800 levels, followed by a possible bounce back. Fundamentally Sanofi is a good stock currently trading at a P/E of 30.
NSE:SANOFIShort
by Nar
Ajanta Pharma Breaks Above Ascending TriangleIt is been observed on the hourly chart that the price action breaking above an Ascending Triangle formation, indicating a bullish signal ahead. It has broken the previous resistance levels of 1830-1840 which also indicates and confirms a bullish signal ahead. The target is been measured as per the triangle formation guidelines which also confluence with the another resistance levels at around 1940-1960 levels. Target1: 1880 Target2: 1940 Stoploss: 1800
NSE:AJANTPHARMLong
by NeeteshJain
7